Cumulus Neuroscience
With a background in psychology and neuroscience, Alison is focused on integrating technology into healthcare. She was awarded her Ph.D. from Queen's University Belfast, and has a successful track record in research investigating the utility of biomedical devices and mobile phone apps in clinical settings, including cancer, cardiovascular and neurodegenerative disease. As Director of Clinical Programmes at Cumulus Neuroscience Ltd, Alison is responsible for the design and execution of research studies using the Platform.
This person is not in any offices
Cumulus Neuroscience
Cumulus Neuroscience has created a next-generation integrated physiological and digital biomarker platform. In clinical trials it provides the critical data and insights needed to accelerate the delivery of more effective CNS drugs to patients. This addresses the significant unmet need for faster, more robust and cost-effective execution and evaluation of clinical trials in neuroscience.